期刊文献+

苦寒燥湿及活血通络法治疗类风湿关节炎的临床研究 被引量:2

Treatment of active rheumatoid arthritis with traditional Chinese medicine method of bitter-cold herbs easing dampness plus promoting blood circulation to remove meridian obstruction
下载PDF
导出
摘要 目的评估苦寒燥湿、活血通络法对活动期类风湿关节炎(RA)的临床疗效。方法选择100例活动期RA患者分为治疗组和对照组,治疗组予以三黄一龙汤联合注射用血塞通、非甾体抗炎药(NSAIDs)、非生物制剂抗风湿性药物(DMARDs)治疗,对照组予以NSAIDs、DMARDs治疗,两组均治疗2个疗程。观察治疗前后两组肿胀、压痛关节数,晨僵时间,评价握力及血小板、血沉、C反应蛋白等指标。结果治疗组临床和实验室指标改善早于并优于对照组(P<0.05);治疗组治疗4、8 w后,改善率分别为82%、94%,亦优于对照组的62%和80%(P<0.05)。结论苦寒燥湿、活血通络法治疗RA活动期,能更好、更快地改善临床症状、体征和实验室指标,提高治疗效果,缩短住院时间。 Objective To evaluate the clinical efficiency of the treatment of traditional Chinese medicine method of bitter-cold herbs easing dampness plus Xuesetong injection promoting blood circulation to remove meridian obstruction on active rheumatoid arthritis(RA). Methods 100 cases with active RA were divided into 2 groups:treatment group and control group,50 cases in each;NASIDs and DMARDs were administrated to the cases in both groups,while Sanhuang Yilong decoction and Xuesetong injection were added to cases in treatment group;the course lasted for 2 months;the clinical manifestation and laboratory indexes of the cases in both&amp;nbsp;groups were observed and comparatively analyzed. Results An earlier and superior improvement in clinical manifestation and laboratory indexes was gained in treatment group than that in control group;the rates of improvement in treatment group at the time point of the 4 and 8 weeks after treatment were 82% and 94% ,respectively,much higher than those in control group(62% and 80%respectively)(P ﹤ 0. 05). Conclusions The treatment of bitter-cold herbs easing dampness plus promoting blood circulation to remove meridian obstruction is effective on active RA;it provides a better and faster improvement in clinical manifestation,physical signs and laboratory index so that the time for hospitalization is shortened.
出处 《西南国防医药》 CAS 2014年第7期746-749,共4页 Medical Journal of National Defending Forces in Southwest China
关键词 类风湿关节炎 三黄一龙汤 苦寒燥湿 血塞通 活血通络 rheumatoid arthritis Sanhuang Yilong decoction bitter-cold herbs easing dampness Xuesetong injection promoting blood circulation to remove meridian obstruction
  • 相关文献

参考文献12

  • 1Amett FC ,Edworthy SM,Bloch DA ,et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis[J]. Arthr Rheum,1988,31:315-324.
  • 2Fausto Salaffi ,Marina Carotti ,Alessandro Ciapetti ,et al. Relationship between time-integrated disease activity estimated by DAS28-CRP and radiographic progression of anatomical damage in patients with early rheumatoid arthritis[J]. BMC Musculoskeletal Disorders,2011, 12:120.
  • 3中华人民共和国中医药行业标准.中医病证诊断疗效标准[s].南京:南京大学出版社,1994.79.
  • 4Smolen JS, Aletaha D. The assessment of disease activity in rheu- matoid arthritis [ J ]. Clin Exp Rheumato1,2010 ,28 ( Suppl 59 ) : 18-27.
  • 5Defang Liu, Mingyang Guo, Mingdong Yun, et al. Diagnostic value of serum and joint fluid anti-CCP( citrulline-containing peptide) antibody for rheumatoid arthritis and its relationship with other inflammatory indicators [ J ]. Scientific Research and Essays, 2011,6 ( 12 ) : 2465-2469.
  • 6Li H,Song W,Li Y,et al. Diagnostic value of anti-cyclic citmllinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity[ J ]. Clin Rheumatol,2010,29:413-417.
  • 7Ronnelid J,Wick MC,Lampa J,et al. Longitudinal analysis of citrul- linated protein/peptide antibodies (anti-CCP) during 5 year follow up in early rheumatoid arthritis:anti-CCP status predicts worse disease activity and greater radiological progression [ J ]. Ann Rheum Dis, 2005,64 : 1744-1749.
  • 8Josef S Smolen,Daniel Aletaha,Johannes WJ Bijlsma,et al. Treating rheumatoid arthritis to target: reconunendations of an international task force[J]. Ann Rheum Dis,2010,69:631-637.
  • 9沈应君,李仪奎,张世玮,等.中药药理学[M].上海:上海科学出版社,1997:47,50,77,88-89.
  • 10张毅,林岭,廖福龙,游云.数控剪应力微流装置评价血塞通注射液对胶原诱导血小板黏附与聚集的影响[J].中国药物警戒,2010,7(12):715-718. 被引量:6

二级参考文献23

共引文献36

同被引文献14

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部